In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Gwendolyn M BeachamDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0000-0001-7158-6887 Zewde S IngramDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0000-0003-3615-0273 Reema A ElrefaieDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0009-0009-0294-4164 Khaliun EnkhbayarDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0009-0002-4802-1348 Zachary R ZenerDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0009-0002-6808-9315 Leila AffiniDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0009-0005-7497-9690 Zainab N WasimDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0009-0001-3028-6076 Maura C DodgeDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0000-0002-2348-9465 Sandeep SreeramaCenter for Regenerative Medicine, Department of Medicine, Section of Vascular Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0002-2527-4636 Maria A SerranoCenter for Regenerative Medicine, Department of Medicine, Section of Vascular Biology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.ORCID 0000-0002-4318-3746 Elliott J HagedornDepartment of Medicine, Section of Hematology and Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA, USA.ORCID 0000-0002-3824-3249 Funding
NRSA Training CoreTL1TR001410 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOTTON, DARRELL N. · 2015 to 2024
$4.3MNiche-specific endothelial mechanisms regulating the extravasation of hematopoietic stem cellsR01HL178832 · NHLBI · BOSTON MEDICAL CENTER · PI Elliott Jennings Hagedorn · 2025 to 2026
$1.4MDeconstructing the Hematopoietic Stem Cell NicheK01DK111790 · NIDDK · BOSTON MEDICAL CENTER · PI HAGEDORN, ELLIOTT JENNINGS · 2017 to 2021
$792kFull Spectrum Cell Sorter with Imaging Enhancement for Boston University Flow Cytometry Core FacilityS10OD038346 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BELKINA, ANNA · 2025 to 2025
$656kMechanisms of a conserved niche endothelial program directing hematopoietic stem cell migrationF31HL184822 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Zewde Ingram · 2026 to 2026
$50kNCATS NIH HHS TL1 TR001410NHLBI NIH HHS F31 HL184822NHLBI NIH HHS R01 HL178832NIDDK NIH HHS K01 DK111790NIH HHS S10 OD038346
6 · The paper itselfAbstract
Hematopoietic stem and progenitor cell (HSPC) niches support lifelong production of blood and immune cells. Recently, we identified a gene signature unique to HSPC niche endothelial cells that is highly conserved across species and developmental time and includes the scavenger receptors
Indexed as
blood stem cell nicheerythroid developmentHematopoietic developmentscavenger receptorszebrafish
Identifiers
PMID42465474
PMCPMC13370947
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390